[Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
Postoperative adjuvant hormone therapy and hormone therapy in disseminated breast cancer will be discussed systematically. The classical ablative and additive endocrine therapeutic measures--with the exception of ovarectomy and gestagen therapy--are increasingly being replaced by antagonists. Individual chapters discuss recent experience with combined hormone-radiotherapy or hormone-chemotherapy. In addition, a successful therapy scheme for the treatment of disseminated breast cancer will be presented.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000315:Adrenalectomy; D000616:Aminoglutethimide / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D002369:Castration; D003534:Cyproterone / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006062:Gonadotropins / Q000037:antagonists & inhibitors; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007016:Hypophysectomy; D008593:Menopause; D009362:Neoplasm Metastasis; D011374:Progesterone / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D004967:Estrogens; D006062:Gonadotropins; D006728:Hormones; D013629:Tamoxifen; D000616:Aminoglutethimide; D011374:Progesterone; D003534:Cyproterone; D006854:Hydrocortisone
Hormone und Tumortherapie: Klinischer Stand und Entwicklung der endokrinen Therapie beim Mammakarzinom.